TCIM
TIAA CREF Investment Management’s Esperion Therapeutics ESPR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $1.77M | Sell |
43,977
-9,943
| -18% | -$399K | ﹤0.01% | 2060 |
|
|
2018
Q4 | $2.48M | Sell |
53,920
-2,427
| -4% | -$112K | ﹤0.01% | 1827 |
|
|
2018
Q3 | $2.5M | Buy |
56,347
+6,106
| +12% | +$271K | ﹤0.01% | 2010 |
|
|
2018
Q2 | $1.97M | Buy |
50,241
+10,941
| +28% | +$429K | ﹤0.01% | 2182 |
|
|
2018
Q1 | $2.84M | Buy |
39,300
+1,508
| +4% | +$109K | ﹤0.01% | 1907 |
|
|
2017
Q4 | $2.49M | Sell |
37,792
-4,462
| -11% | -$294K | ﹤0.01% | 2012 |
|
|
2017
Q3 | $2.12M | Buy |
42,254
+3,180
| +8% | +$159K | ﹤0.01% | 2135 |
|
|
2017
Q2 | $1.81M | Buy |
39,074
+1,148
| +3% | +$53.1K | ﹤0.01% | 2238 |
|
|
2017
Q1 | $1.34M | Sell |
37,926
-984
| -3% | -$34.7K | ﹤0.01% | 2365 |
|
|
2016
Q4 | $487K | Sell |
38,910
-6,395
| -14% | -$80K | ﹤0.01% | 2862 |
|
|
2016
Q3 | $627 | Hold |
45,305
| – | – | ﹤0.01% | 2762 |
|
|
2016
Q2 | $448K | Buy |
45,305
+2,370
| +6% | +$23.4K | ﹤0.01% | 2910 |
|
|
2016
Q1 | $726K | Sell |
42,935
-12,086
| -22% | -$204K | ﹤0.01% | 2634 |
|
|
2015
Q4 | $1.23M | Sell |
55,021
-575
| -1% | -$12.8K | ﹤0.01% | 2463 |
|
|
2015
Q3 | $1.31M | Buy |
55,596
+12,391
| +29% | +$292K | ﹤0.01% | 2399 |
|
|
2015
Q2 | $3.53M | Buy |
43,205
+19,662
| +84% | +$1.61M | ﹤0.01% | 1930 |
|
|
2015
Q1 | $2.18M | Buy |
23,543
+3,934
| +20% | +$364K | ﹤0.01% | 2169 |
|
|
2014
Q4 | $793K | Sell |
19,609
-86
| -0.4% | -$3.48K | ﹤0.01% | 2785 |
|
|
2014
Q3 | $482K | Hold |
19,695
| – | – | ﹤0.01% | 2982 |
|
|
2014
Q2 | $312K | Buy |
19,695
+3,237
| +20% | +$51.3K | ﹤0.01% | 3064 |
|
|
2014
Q1 | $249K | Buy |
16,458
+6,700
| +69% | +$101K | ﹤0.01% | 3059 |
|
|
2013
Q4 | $134K | Hold |
9,758
| – | – | ﹤0.01% | 3102 |
|
|
2013
Q3 | $184K | Buy |
+9,758
| New | +$184K | ﹤0.01% | 3058 |
|